Workload and goals of the Unit.................................................................. ..11 The Committee for Proprietary Medicinal Products.................................... .12 Centralised applications for marketing authorisations................................. ..14 Maintenance, variations and pharmacovigilance activities........................... .15 Arbitration and other Community referral procedures................................. ..16 Scientific advice to future applicants............................................................ .16 Information to health care professionals and patients................................. ..17 Technical support to international harmonisation initiatives........................ 17 Support for mutual recognition of national authorisations........................... ..17